Literature DB >> 16609821

Seronegative arthritis in patient with solitary bone plasmacytoma.

Anna Blach1, Elzbieta Zycinska-Debska, Aleksandra Zon-Giebel, Michal Banas, Anna Kotulska, Eugene J Kucharz.   

Abstract

We report a patient with localized focus of the bone destruction due to a rare disease, solitary bone plasmacytoma (SBP). The patient suffered from arthritis, mimicking seronegative rheumatoid arthritis. To our knowledge, it is the first description of coexistence of arthritis and SBP.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16609821     DOI： 10.1007/s10067-006-0291-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   3.650


  6 in total

1.  Solitary bone and extramedullary plasmacytoma.

Authors:  Donna M Weber
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

2.  Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma.

Authors:  Richard Soutar; Helen Lucraft; Graham Jackson; Anthony Reece; Jenny Bird; Eric Low; Diana Samson
Journal:  Clin Oncol (R Coll Radiol)       Date:  2004-09       Impact factor: 4.126

3.  Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome.

Authors:  R W Tsang; M K Gospodarowicz; M Pintilie; A Bezjak; W Wells; D C Hodgson; A K Stewart
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-05-01       Impact factor: 7.038

Review 4.  Paraneoplastic rheumatic syndromes.

Authors:  Csilla András; Zoltán Csiki; Andrea Ponyi; Arpád Illés; Katalin Dankó
Journal:  Rheumatol Int       Date:  2005-08-10       Impact factor: 2.631

5.  Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.

Authors:  Richard B Wilder; Chul S Ha; James D Cox; Donna Weber; Kay Delasalle; Raymond Alexanian
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

Review 6.  Solitary bone plasmacytoma and extramedullary plasmacytoma.

Authors:  Meletios A Dimopoulos; George Hamilos
Journal:  Curr Treat Options Oncol       Date:  2002-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.